Cargando…

Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study

The aim of this prospective open-label study was to treat disabling drooling in children with cerebral palsy (CP) with onabotulinumtoxin A (A/Ona, Botox(®)) into submandibular and parotid glands and find the lowest effective dosage and least invasive method. A/Ona was injected in 14 children, Mean a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Møller, Eigild, Pedersen, Søren Anker, Vinicoff, Pablo Gustavo, Bardow, Allan, Lykkeaa, Joan, Svendsen, Pia, Bakke, Merete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516924/ https://www.ncbi.nlm.nih.gov/pubmed/26134257 http://dx.doi.org/10.3390/toxins7072481

Ejemplares similares

The association of drooling and health-related quality of life in children with cerebral palsy
por: Chang, Shih-Chung, et al.
Publicado: (2012)

Effects of treatments for drooling on caries risk in children and adolescents with cerebral palsy
por: Gutierrez, Gabriela-Mancia, et al.
Publicado: (2019)

Acupuncture for drooling in children with cerebral palsy: A protocol for systematic review
por: Xiong, Wei, et al.
Publicado: (2021)

An investigation of the relationship of drooling with nutrition and head control in individuals with quadriparetic cerebral palsy
por: Taş, Seda Ayaz, et al.
Publicado: (2015)

Interdisciplinary recognizing and managing of drug‐induced tardive oromandibular dystonia: two case reports
por: Bakke, Merete, et al.
Publicado: (2018)

Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy
por: Bekkers, Stijn, et al.
Publicado: (2020)

Can muscle vibration be the future in the treatment of cerebral palsy-related drooling? A feasibility study.
por: Russo, Emanuele F., et al.
Publicado: (2019)

Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
por: Hung, Shang-An, et al.
Publicado: (2021)

Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy
por: Reyes, Fabiola I., et al.
Publicado: (2022)

Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions
por: Zeller, Robert S, et al.
Publicado: (2012)

Debilitating consequences of drooling
por: Bloem, B. R., et al.
Publicado: (2009)

Drools Developer's Cookbook
por: Amador, Lucas
Publicado: (2012)

Instant Drools starter
por: Ary, Jeremy
Publicado: (2013)

Introduction to Rule Engines with Drools
por: Fusco, Mario
Publicado: (2015)

JBoss Drools Business Rules
por: Browne, Paul
Publicado: (2009)

Surgical Management of the Drooling Child
por: Lawrence, Rachael, et al.
Publicado: (2018)

The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability
por: Parr, Jeremy R, et al.
Publicado: (2014)

Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability
por: Parr, Jeremy R, et al.
Publicado: (2018)

Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Gormley, Mark, et al.
Publicado: (2023)

Diurnal and nocturnal drooling in Parkinson’s disease
por: Kalf, J. G., et al.
Publicado: (2011)

How Much Drool Is Too Much?()
por: Schubert, Gena, et al.
Publicado: (2019)

Pathophysiology and Symptomatology of Drooling in Parkinson’s Disease
por: Polychronis, Sotirios, et al.
Publicado: (2022)

Evaluation of an intensive voice treatment to reduce anterior drooling in children with cerebral palsy: Protocol for a concurrent multiple-baseline, single case experimental design study
por: McInerney, Michelle, et al.
Publicado: (2021)

Drools jboss rules 5.0 developer's guide: develop rules-based business logic using the Drools platform
por: Bali, Michal
Publicado: (2009)

Mastering JBoss Drools 6: discover the power of Drools 6 and Business Rules for developing complex scenarios in your applications
por: Aliverti, Esteban
Publicado: (2016)

Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions
por: Zeller, Robert S, et al.
Publicado: (2012)

Joubert syndrome labeled as hypotonic cerebral palsy
por: Dekair, Lubna H., et al.
Publicado: (2014)

Drools JBoss rules 5.5 developer's guide
por: Bali, Michal
Publicado: (2013)

The Danish Cerebral Palsy Follow-up Program
por: Rasmussen, Helle Mätzke, et al.
Publicado: (2016)

Management of drooling for patients in the north of Iran: Analysis of the surgical management
por: Naghavi, Seyed Ebrahim, et al.
Publicado: (2010)

Prevalence and definition of drooling in Parkinson’s disease: a systematic review
por: Kalf, J. G., et al.
Publicado: (2009)

Botulinum Toxin in the Treatment of Drooling in Tetraplegic Patients With Brain Injury
por: Ko, Sung Hwa, et al.
Publicado: (2013)

An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities
por: Bekkers, Stijn, et al.
Publicado: (2020)

Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability
por: Bekkers, Stijn, et al.
Publicado: (2021)

Drooling outcome measures in paediatric disability: a systematic review
por: Sforza, E., et al.
Publicado: (2022)

Translation and validation of the drooling impact scale questionnaire into Brazilian Portuguese
por: Cavalcanti, Natália Silva, et al.
Publicado: (2020)

Expiratory Muscle Strength Training for Drooling in Adults with Parkinson’s Disease
por: Cocks, Naomi, et al.
Publicado: (2022)

Drooling disrupts the brain functional connectivity network in Parkinson's disease
por: Huang, Ting, et al.
Publicado: (2023)

OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients
por: Miller, Sarah, et al.
Publicado: (2015)

OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients
por: García-Sáez, Rafael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ob77r0si98evdfenikubl7ia5d